Share
When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Manage episode 508575007 series 2902118
Content provided by ACCP JOURNALS. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ACCP JOURNALS or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Dr. Arden Barry shares his team's findings from their large population database when evaluating the effect of exposure to P2Y12 inhibitors, versus no exposure, on the occurrence of major adverse cardiovascular events. The results support the use of P2Y12 inhibitors (primarily clopidogrel), in addition to other standard cardiovascular preventive therapy, in patients who undergo CABG surgery, but take a listen for all the details. Access the OPEN ACCESS manuscript here: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70047
173 episodes
))
